INCR vs. TEVA

In the year-to-date period, INCR achieves a -4.40% return, which is significantly higher than TEVA's -18.51% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for INC Research Holdings Inc (INCR) and Teva Pharmaceutical Industries Limited (TEVA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current INCR Sharpe Ratio is -0.78, which is lower than the TEVA Sharpe Ratio of 0.22. The chart below compares the historical Sharpe Ratios of INCR and TEVA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither INCR nor TEVA has paid dividends to shareholders.

The maximum INCR drawdown since its inception was -94.32%, roughly equal to the maximum TEVA drawdown of -90.80%. Use the drawdown chart below to compare losses from any high point for INCR and TEVA. For additional features, visit the drawdowns tool.

INC Research Holdings Inc (INCR) and Teva Pharmaceutical Industries Limited (TEVA) have volatilities of 15.02% and 15.01%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between INC Research Holdings Inc and Teva Pharmaceutical Industries Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.